Drug Type Small molecule drug |
Synonyms |
Target |
Action modulators |
Mechanism AMHR2 modulators(Anti-Mullerian hormone receptor II modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Ovarian Diseases | Preclinical | United States | 07 Aug 2023 | |
| Ovarian Diseases | Preclinical | United States | 07 Aug 2023 |





